NewsBenzingaDBVテクノロジーズ、4~7歳のピーナッツアレルギー児を対象としたVIASKINピーナッツパッチについてFDAにBLAを提出、優先審査を要請 DBVテクノロジーズ、4~7歳のピーナッツアレルギー児を対象としたVIASKINピーナッツパッチについてFDAにBLAを提出、優先審査を要請 Benzinga 2026.09.30 07:43 (GMT+0) Open on Benzinga Other news Deutsche Bank Initiates Coverage On FormFactor with Buy Rating, Announces Price Target of $200 SBI, Mesh, Money Forward to Form Japan Digital Asset Joint Venture Full Transcript: Rockwell Automation Q3 2026 Earnings Call Meta avoided billions in federal taxes by classifying its data centers as experimental facilities Coinbase Receives CFTC Approval to Operate a Derivatives Clearing Organization Piper Sandler Maintains Overweight on Microsoft, Raises Price Target to $610